Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Sell
14,357
-84
-0.6% -$9.83K 1.15% 27
2026
Q1
$1.74M Hold
14,441
1.2% 26
2025
Q4
$1.52M Sell
14,441
-78
-0.5% -$7.32K 1.05% 28
2025
Q3
$1.22M Sell
14,519
-272
-2% -$22.4K 0.85% 34
2025
Q2
$1.17M Sell
14,791
-242
-2% -$19.2K 0.93% 31
2025
Q1
$1.35M Sell
15,033
-568
-4% -$53K 1.09% 26
2024
Q4
$1.55M Sell
15,601
-200
-1% -$20.6K 1.25% 25
2024
Q3
$1.79M Buy
15,801
+57
+0.4% +$6.77K 1.47% 18
2024
Q2
$1.95M Sell
15,744
-271
-2% -$34.9K 1.66% 16
2024
Q1
$2.11M Sell
16,015
-90
-0.6% -$11.1K 1.74% 15
2023
Q4
$1.76M Sell
16,105
-671
-4% -$69.7K 1.52% 17
2023
Q3
$1.73M Sell
16,776
-54
-0.3% -$5.82K 1.66% 16
2023
Q2
$1.94M Buy
+16,830
New +$1.91M 1.88% 13

Other funds holding MRK

Exchange Bank's MRK Position: Q2 2026 in Review

Exchange Bank reduced its Merck (MRK) stake by 0.58% in Q2 2026, selling an estimated $9.83K and leaving 14,357 shares worth $1.84M. The position accounts for 1.15% of the portfolio, ranked #27.

Exchange Bank first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.11M in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Exchange Bank held 14,357 shares of Merck worth $1.84M as of Q2 2026.
  • Exchange Bank sold 84 Merck shares in Q2 2026, an estimated $9.83K.
  • Merck made up 1.15% of Exchange Bank's portfolio in Q2 2026, its #27 holding.
  • Exchange Bank first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
  • Exchange Bank's Merck position peaked at $2.11M in Q1 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Exchange Bank's 13F filing for Q2 2026, filed 9 Jul 2026.